You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Regulating Nanomedicine at the Food and Drug Administration
AMA Journal of Ethics, April 2019
The data shown below were collected from the profiles of 8 tweeters who shared this research output. Click here to find out more about how the information was compiled.
|Members of the public||7||88%|
The data shown below were compiled from readership statistics for 99 Mendeley readers of this research output. Click here to see the associated Mendeley record.
|Readers by professional status||Count||As %|
|Student > Ph. D. Student||22||22%|
|Student > Bachelor||18||18%|
|Student > Master||14||14%|
|Student > Doctoral Student||6||6%|
|Readers by discipline||Count||As %|
|Pharmacology, Toxicology and Pharmaceutical Science||26||26%|
|Biochemistry, Genetics and Molecular Biology||9||9%|
|Medicine and Dentistry||7||7%|
|Agricultural and Biological Sciences||5||5%|